The Effect of Octreotide as an Adjunct Treatment in Active Nonvariceal Upper Gastrointestinal Bleeding

Journal of Clinical Gastroenterology

Volumn 38, Issue 3, 2004, Pages 243-247

  Nikolopoulou, Vassiliki N ^a,b   Thomopoulos, Konstantin C ^a   Katsakoulis, Evangelos C ^a   Vasilopoulos, Apostolos G ^a   Margaritis, Vassilios G ^a   Vagianos, Constantin E ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Nonvariceal acute upper gastrointestinal bleeding; Octreotide

Indexed keywords

NORADRENALIN; OCTREOTIDE; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DUODENUM ULCER; ENDOSCOPIC THERAPY; ENDOVASCULAR SURGERY; FEMALE; HELICOBACTER PYLORI; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STOMACH ULCER; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VESSEL;

AGED; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL AGENTS; HEMOSTASIS, ENDOSCOPIC; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1242285131     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200403000-00009     Document Type: Article

References (39)

1. Laine L. Medical progress: bleeding peptic ulcer. N Engl J Med. 1994;331:717-727.
2. Rockall TA, Logan RF, Devlin HB, et al. Steering audit of acute upper gastrointestinal haemorrhage. Incidence and mortality from acute upper gastrointestinal hemorrhage in the United Kindom. Br Med J. 1995;311:222-226.
3. Turner IB, Jones M, Piper DW. Factors influencing mortality from bleeding peptic ulcers. Sacand J Gastroenterol. 1991;26:661-666.
4. Rajgopal C, Palmer KR. Endoscopic injection sclerosis: effective treatment for bleeding peptic ulcer. Gut. 1991;32:727-729.
5. Meier R, Wettstein A. Treatment of acute nonvariceal upper gastrointestinal hemorrhage. Digestion. 1999;60:47-52.
6. Thomopoulos K, Nikolopoulou V, Katsakoulis E, et al. The effect of endoscopic therapy on the clinical outcome of patients with peptic ulcer bleeding. Scand J Gastroenterol. 1997;32:212-216.
7. Holman RAE, Davis M, Gough KR, et al. Value of centralized approach in the management of haematemesis and melaena: experience in a distinct general hospital. Gut. 1990;31:504-508.
8. Silverstein FE, Gilbert DA, Tedesco FJ, et al. The national ASGE survey on upper gastrointestinal bleeding. Gastrointest Endosc. 1981;27:80-93.
9. Villaneueva C, Balanzo J, Espinos JC, et al. Endoscopic injection therapy of bleeding ulcer: a prospective and randomized comparison of adrenaline alone or with polidocanol. J Clin Gastroenterol. 1993;17:195-200.
10. Cook DJ, Guyat GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage. A metaanalysis. Gastroenterology. 1992;102:139-148.
11. Van der Mierop F, Fleisher DE. Endoscopic hemostasis in nonvariceal bleeding: an overview. Endoscopy. 1996;28:54-65.
12. Saltzman JR, Zawacki JK. Therapy for bleeding peptic ulcers. N Engl J Med. 1997;336:1091.
13. Thomopoulos K, Mitropoulos I, Katsakoulis E, et al. Factors associated with failure of endoscopic injection haemostasis in bleeding peptic ulcers. Scand J Gastroenterol. 2001;36:664-668.
14. Swain P. What should be done when initial endoscopic therapy for bleeding peptic ulcer fails? Endoscopy. 1995;27:321-328.
15. Lee JG. Prevention of ulcer rebleeding and recurrence. ASGE Postgraduate Course: Frontiers of Therapeutic Endoscopy; 1997:17-19.
16. Brullet E, Calvet X, Champo R, et al. Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc. 1996;42:111-116.
17. Krejs GJ. Physiological role of somatostatin in the digestive tract: Gastric acid secretion, intestinal absorption and motility. Scand J Gastroenterol. 1986;2:47-53.
18. Arnold R, Lakish PG. Somatostatin and the gastrointestinal track. Clin Gastroenterol. 1980;9:733-753.
19. Lembcke B, Creutzfeld W, Schleser S, et al. Effect of the somatostatin analogue Sandostatin (SMS 201 995) on gastrointestinal, pancreatic and biliary function and hormone release in normal man. Digestion. 1987;36:108-124.
20. Jenkins S, Poulianos G, Coraggio F, et al. Somatostatin in the treatment of non-variceal upper gastrointestinal bleeding. Dig Dis. 1998;16:214-224.
21. Imperiale F, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Ann Intern Med. 1997;127:1062-1071.
22. Lin HJ, Perng CL, Wang K, et al. Octreotide for arrest of peptic ulcer hemorrhage - a prospective, randomized controlled trial. Hepatogastroenterology. 1995;42:856-860.
23. Coragio F, Bertim G, Catalano A, et al. Clinical controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract. Digestion. 1989;43:190-195.
24. Lin HJ, Wang K, Perng CL, et al. Octreotide and heater probe thermocoagulation for arrest of peptic ulcer hemorrhage. A prospective, randomized, controlled trial. J Clin Gastroenterol. 1995;21:95-98.
25. Coragio F, Rotondano G, Marmo R, et al. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report. Eur J Gastroenterol. 1998;10:673-676.
26. Lambropoulos LG, Greca A, Bakaris T, et al. Somatostatin effectiveness in serious upper gastrointestinal hemorrhage. Gut. 1996;39:A204.
27. Forrest JAH, Finlayson NDC, Shearman DJC. Endoscopy in gastrointestinal bleeding. Lancet. 1974;ii:394-397.
28. Villanueva C, Balanzo J, Torras X, et al. Value of a second - look endoscopy after injection therapy for bleeding peptic ulcer. A prospective randomized trial. Gastrointest Endosc. 1994;40:34-39.
29. Messmann H, Schaller P, Andus T, et al. Effect of programmed endoscopic follow - up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy. 1998;30:583-589.
30. Somerville KW, Henry DA, Davies JG, et al. Somatostatin in the treatment of haematemesis and maelena. Lancet. 1985;1:130-132.
31. Coraggio F, Rotondano G, Marmo R, et al. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report. Eur J Gastroenterol Hepatol. 1998;10:673-676.
32. Basso N, Bagarani M, Bracci F, et al. Ranitidine and somatostatin. Their effect on bleeding from the upper gastrointestinal tract. Arch Surg. 1986;121:833-835.
33. Tulassay Z, Gupta R, Papp J, et al. Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective randomized, controlled trial. Am J Gastroenterol. 1989;84:6-9.
34. Christiansen J, Ottenjann R, Von Arx F. Placebo controlled trial with the somatostatin analogue SMS 201 995 in peptic ulcer bleeding. Gastroenterology. 1989;97:568-574.
35. Okan A, Simsek I, Akpinar H, et al. Somatostatin and ranitidine in the treatment of non-variceal upper gastrointestinal bleeding: a prospective randomized, double-blind, controlled study. Hepatogastroenterology. 2000;47:1325-1327.
36. Antonioli A, Gandolfo M, Rigo GP, et al. Somatostatin and cimetidine in the control of acute upper gastrointestinal bleeding. A controlled multicenter study. Hepatogastroenterology. 1986;33:71-74.
37. Archimadritis A, Tsirantonaki M, Tryphonos M, et al. Ranitidine versus ranitidine plus octreotide in the treatment of acute non-variceal upper gastrointestinal bleeding: a prospective randomized study. Curr Med Res Opin. 2000;16:178-183.
38. Kullavanuaya P, Manotaya S, Thong-Ngam D, et al. Efficacy of octreotide in the control of acute upper gastrointestinal bleeding. J Med Assoc Thai. 2001;84:1714-20.
39. Lin H, Tseng G, Lo W, et al. Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation. J Clin Gastroenterol. 1996;26:113-116.